Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis

Clinical trial NCT06466421 · COMPLETED

Trial details

NCT number: NCT06466421
Sponsor: Tanta University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Uremic Pruritus Chronic Kidney Disease-associated Pruritus Hemodialysis End-stage Renal Disease Renal Replacement Therapy ESRD

Start date: 2024-07-01
Primary completion: 2024-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.